Bio-Techne Corporation (TECH)
USD 50.06
(-3.21%)
USD 50.06
(-3.21%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 773.07 Million USD | -0.01% |
| 2023 | 769.81 Million USD | 1.76% |
| 2022 | 756.49 Million USD | 19.54% |
| 2021 | 632.85 Million USD | 30.97% |
| 2020 | 483.19 Million USD | 2.05% |
| 2019 | 473.49 Million USD | 9.57% |
| 2018 | 432.14 Million USD | 15.38% |
| 2017 | 374.54 Million USD | 11.25% |
| 2016 | 336.65 Million USD | 9.56% |
| 2015 | 307.27 Million USD | 22.22% |
| 2014 | 251.41 Million USD | 8.78% |
| 2013 | 231.11 Million USD | -1.99% |
| 2012 | 235.8 Million USD | 4.83% |
| 2011 | 224.93 Million USD | 4.82% |
| 2010 | 214.58 Million USD | 2.93% |
| 2009 | 208.46 Million USD | 1.92% |
| 2008 | 204.53 Million USD | 15.68% |
| 2007 | 176.81 Million USD | 12.69% |
| 2006 | 156.89 Million USD | 10.62% |
| 2005 | 141.83 Million USD | 12.24% |
| 2004 | 126.37 Million USD | 15.29% |
| 2003 | 109.61 Million USD | 11.41% |
| 2002 | 98.39 Million USD | 13.18% |
| 2001 | 86.93 Million USD | 7.98% |
| 2000 | 80.5 Million USD | 22.17% |
| 1999 | 65.9 Million USD | 33.13% |
| 1998 | 49.5 Million USD | 12.76% |
| 1997 | 43.9 Million USD | 17.07% |
| 1996 | 37.5 Million USD | 21.36% |
| 1995 | 30.9 Million USD | 23.11% |
| 1994 | 25.1 Million USD | 48.52% |
| 1993 | 16.9 Million USD | 33.07% |
| 1992 | 12.7 Million USD | 22.12% |
| 1991 | 10.4 Million USD | 23.81% |
| 1990 | 8.4 Million USD | 31.25% |
| 1989 | 6.4 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 176.58 Million USD | -4.65% |
| 2024 Q1 | 185.19 Million USD | -9.53% |
| 2024 Q3 | 205.24 Million USD | 16.23% |
| 2024 Q4 | 204.87 Million USD | -0.18% |
| 2024 FY | 773.07 Million USD | 0.42% |
| 2023 FY | 769.81 Million USD | 1.76% |
| 2023 Q1 | 179.59 Million USD | -10.36% |
| 2023 Q2 | 183.36 Million USD | 2.1% |
| 2023 Q4 | 204.69 Million USD | 1.25% |
| 2023 Q3 | 202.16 Million USD | 10.25% |
| 2022 Q3 | 201.45 Million USD | 9.67% |
| 2022 Q4 | 200.35 Million USD | -0.55% |
| 2022 FY | 756.49 Million USD | 19.54% |
| 2022 Q2 | 183.69 Million USD | 7.42% |
| 2022 Q1 | 170.99 Million USD | -2.81% |
| 2021 Q3 | 168.27 Million USD | 11.51% |
| 2021 Q4 | 175.94 Million USD | 4.56% |
| 2021 Q1 | 137.73 Million USD | 21.55% |
| 2021 Q2 | 150.9 Million USD | 9.56% |
| 2021 FY | 632.85 Million USD | 30.97% |
| 2020 Q4 | 113.31 Million USD | -12.88% |
| 2020 Q1 | 118.41 Million USD | -7.68% |
| 2020 Q2 | 121.4 Million USD | 2.52% |
| 2020 Q3 | 130.06 Million USD | 7.13% |
| 2020 FY | 483.19 Million USD | 2.05% |
| 2019 FY | 473.49 Million USD | 9.57% |
| 2019 Q1 | 107.6 Million USD | -11.93% |
| 2019 Q4 | 128.25 Million USD | 2.93% |
| 2019 Q3 | 124.61 Million USD | 10.26% |
| 2019 Q2 | 113.01 Million USD | 5.03% |
| 2018 Q1 | 97.86 Million USD | -4.4% |
| 2018 FY | 432.14 Million USD | 15.38% |
| 2018 Q4 | 122.18 Million USD | 10.81% |
| 2018 Q3 | 110.26 Million USD | 8.28% |
| 2018 Q2 | 101.83 Million USD | 4.05% |
| 2017 Q2 | 85.08 Million USD | 0.72% |
| 2017 Q3 | 94.18 Million USD | 10.7% |
| 2017 Q1 | 84.47 Million USD | -5.82% |
| 2017 FY | 374.54 Million USD | 11.25% |
| 2017 Q4 | 102.37 Million USD | 8.69% |
| 2016 Q1 | 75.39 Million USD | -4.67% |
| 2016 FY | 336.65 Million USD | 9.56% |
| 2016 Q2 | 81.58 Million USD | 8.22% |
| 2016 Q4 | 89.69 Million USD | -0.33% |
| 2016 Q3 | 89.98 Million USD | 10.3% |
| 2015 Q3 | 79.38 Million USD | 4.8% |
| 2015 FY | 307.27 Million USD | 22.22% |
| 2015 Q4 | 79.08 Million USD | -0.37% |
| 2015 Q2 | 75.74 Million USD | 3.66% |
| 2015 Q1 | 73.06 Million USD | 14.9% |
| 2014 Q1 | 61.11 Million USD | 3.38% |
| 2014 Q2 | 58.59 Million USD | -4.13% |
| 2014 FY | 251.41 Million USD | 8.78% |
| 2014 Q4 | 63.59 Million USD | -6.63% |
| 2014 Q3 | 68.11 Million USD | 16.24% |
| 2013 FY | 231.11 Million USD | -1.99% |
| 2013 Q4 | 59.11 Million USD | -3.32% |
| 2013 Q3 | 61.14 Million USD | 10.65% |
| 2013 Q2 | 55.26 Million USD | -0.58% |
| 2013 Q1 | 55.58 Million USD | -5.57% |
| 2012 Q1 | 58.38 Million USD | -1.55% |
| 2012 Q3 | 63.38 Million USD | 14.89% |
| 2012 Q2 | 55.17 Million USD | -5.51% |
| 2012 Q4 | 58.86 Million USD | -7.13% |
| 2012 FY | 235.8 Million USD | 4.83% |
| 2011 Q4 | 59.3 Million USD | -1.87% |
| 2011 FY | 224.93 Million USD | 4.82% |
| 2011 Q1 | 52.7 Million USD | -0.33% |
| 2011 Q2 | 52.49 Million USD | -0.41% |
| 2011 Q3 | 60.43 Million USD | 15.14% |
| 2010 Q1 | 53.63 Million USD | 6.77% |
| 2010 FY | 214.58 Million USD | 2.93% |
| 2010 Q4 | 52.88 Million USD | -5.37% |
| 2010 Q3 | 55.87 Million USD | 7.06% |
| 2010 Q2 | 52.19 Million USD | -2.69% |
| 2009 Q2 | 48.44 Million USD | -13.86% |
| 2009 Q3 | 53.55 Million USD | 10.54% |
| 2009 Q4 | 50.23 Million USD | -6.19% |
| 2009 FY | 208.46 Million USD | 1.92% |
| 2009 Q1 | 56.23 Million USD | 4.37% |
| 2008 FY | 204.53 Million USD | 15.68% |
| 2008 Q3 | 55.37 Million USD | 12.12% |
| 2008 Q1 | 45.88 Million USD | 0.34% |
| 2008 Q2 | 49.39 Million USD | 7.65% |
| 2008 Q4 | 53.88 Million USD | -2.7% |
| 2007 Q4 | 45.72 Million USD | -5.09% |
| 2007 FY | 176.81 Million USD | 12.69% |
| 2007 Q3 | 48.17 Million USD | 15.27% |
| 2007 Q2 | 41.79 Million USD | 1.66% |
| 2007 Q1 | 41.11 Million USD | 2.16% |
| 2006 Q2 | 37.33 Million USD | 1.97% |
| 2006 Q1 | 36.61 Million USD | -2.89% |
| 2006 FY | 156.89 Million USD | 10.62% |
| 2006 Q4 | 40.24 Million USD | -5.77% |
| 2006 Q3 | 42.7 Million USD | 14.39% |
| 2005 Q1 | 32.03 Million USD | -4.73% |
| 2005 FY | 141.83 Million USD | 12.24% |
| 2005 Q2 | 33.3 Million USD | 3.98% |
| 2005 Q4 | 37.7 Million USD | -2.82% |
| 2005 Q3 | 38.79 Million USD | 16.49% |
| 2004 Q1 | 29.33 Million USD | -1.73% |
| 2004 Q3 | 33.59 Million USD | 12.65% |
| 2004 Q4 | 33.62 Million USD | 0.08% |
| 2004 Q2 | 29.82 Million USD | 1.68% |
| 2004 FY | 126.37 Million USD | 15.29% |
| 2003 Q4 | 29.84 Million USD | 2.99% |
| 2003 Q3 | 28.98 Million USD | 16.25% |
| 2003 FY | 109.61 Million USD | 11.41% |
| 2003 Q1 | 25.85 Million USD | -4.57% |
| 2003 Q2 | 24.92 Million USD | -3.59% |
| 2002 FY | 98.39 Million USD | 13.18% |
| 2002 Q1 | 22.29 Million USD | 60.28% |
| 2002 Q2 | 23.1 Million USD | 3.65% |
| 2002 Q3 | 25.89 Million USD | 12.05% |
| 2002 Q4 | 27.09 Million USD | 4.65% |
| 2001 FY | 86.93 Million USD | 7.98% |
| 2001 Q4 | 13.91 Million USD | -46.31% |
| 2001 Q3 | 25.9 Million USD | 24.24% |
| 2001 Q2 | 20.85 Million USD | -4.41% |
| 2001 Q1 | 21.81 Million USD | -0.72% |
| 2000 Q3 | 20.39 Million USD | 8.48% |
| 2000 Q1 | 18.4 Million USD | 3.95% |
| 2000 Q2 | 18.8 Million USD | 2.17% |
| 2000 FY | 80.5 Million USD | 22.17% |
| 2000 Q4 | 21.97 Million USD | 7.75% |
| 1999 Q4 | 17.7 Million USD | 3.51% |
| 1999 Q3 | 17.1 Million USD | 7.55% |
| 1999 FY | 65.9 Million USD | 33.13% |
| 1999 Q2 | 15.9 Million USD | 4.61% |
| 1999 Q1 | 15.2 Million USD | 7.8% |
| 1998 Q4 | 14.1 Million USD | 10.16% |
| 1998 Q3 | 12.8 Million USD | 15.32% |
| 1998 Q2 | 11.1 Million USD | -4.31% |
| 1998 Q1 | 11.6 Million USD | -3.33% |
| 1998 FY | 49.5 Million USD | 12.76% |
| 1997 Q1 | 9.7 Million USD | -7.62% |
| 1997 FY | 43.9 Million USD | 17.07% |
| 1997 Q2 | 10.4 Million USD | 7.22% |
| 1997 Q3 | 11.8 Million USD | 13.46% |
| 1997 Q4 | 12 Million USD | 1.69% |
| 1996 FY | 37.5 Million USD | 21.36% |
| 1996 Q4 | 10.5 Million USD | 2.94% |
| 1996 Q3 | 10.2 Million USD | 22.89% |
| 1996 Q1 | 8.5 Million USD | -2.3% |
| 1996 Q2 | 8.3 Million USD | -2.35% |
| 1995 Q1 | 6.9 Million USD | -1.43% |
| 1995 Q2 | 7.4 Million USD | 7.25% |
| 1995 Q3 | 8 Million USD | 8.11% |
| 1995 Q4 | 8.7 Million USD | 8.75% |
| 1995 FY | 30.9 Million USD | 23.11% |
| 1994 Q1 | 5.5 Million USD | 25.0% |
| 1994 FY | 25.1 Million USD | 48.52% |
| 1994 Q3 | 6.9 Million USD | 23.21% |
| 1994 Q4 | 7 Million USD | 1.45% |
| 1994 Q2 | 5.6 Million USD | 1.82% |
| 1993 FY | 16.9 Million USD | 33.07% |
| 1993 Q1 | 3.7 Million USD | -13.95% |
| 1993 Q2 | 4 Million USD | 8.11% |
| 1993 Q3 | 4.6 Million USD | 15.0% |
| 1993 Q4 | 4.4 Million USD | -4.35% |
| 1992 Q4 | 4.3 Million USD | 26.47% |
| 1992 Q3 | 3.4 Million USD | 30.77% |
| 1992 Q2 | 2.6 Million USD | -3.7% |
| 1992 FY | 12.7 Million USD | 22.12% |
| 1992 Q1 | 2.7 Million USD | -6.9% |
| 1991 Q2 | 2.5 Million USD | 19.05% |
| 1991 Q4 | 2.9 Million USD | -3.33% |
| 1991 Q1 | 2.1 Million USD | -16.0% |
| 1991 Q3 | 3 Million USD | 20.0% |
| 1991 FY | 10.4 Million USD | 23.81% |
| 1990 FY | 8.4 Million USD | 31.25% |
| 1990 Q4 | 2.5 Million USD | 19.05% |
| 1990 Q2 | 1.9 Million USD | 5.56% |
| 1990 Q3 | 2.1 Million USD | 10.53% |
| 1990 Q1 | 1.8 Million USD | 0.0% |
| 1989 FY | 6.4 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -1933.068% |
| Alkermes plc | 1.37 Billion USD | 43.763% |
| Agenus Inc. | 139.61 Million USD | -453.718% |
| Aptorum Group Limited | -1.11 Million USD | 69453.398% |
| Ardelyx, Inc. | 106.66 Million USD | -624.795% |
| Dyadic International, Inc. | 922.95 Thousand USD | -83660.565% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -3570.642% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 442253.246% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 5887.414% |
| Novavax, Inc. | 639.93 Million USD | -20.805% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 1750.492% |
| Pyxis Oncology, Inc. | -2 Million USD | 38753.7% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 149704.254% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -3959.623% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 1749611.18% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 146793.359% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 887.108% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -96293.267% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 942873.171% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -471.509% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -9721.802% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 897.395% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 49.069% |
| AlloVir, Inc. | -398 Thousand USD | 194339.698% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -221.131% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -182228.774% |
| Bicycle Therapeutics plc | -129.52 Million USD | 696.876% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -644128.333% |
| ChromaDex Corporation | 50.78 Million USD | -1422.399% |
| Chimerix, Inc. | 324 Thousand USD | -238503.086% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 2580.372% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 1096.255% |
| CRISPR Therapeutics AG | 240.95 Million USD | -220.836% |
| Precision BioSciences, Inc. | 40.47 Million USD | -1810.145% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 887.541% |
| Fortress Biotech, Inc. | 57.85 Million USD | -1236.273% |
| Fortress Biotech, Inc. | 57.85 Million USD | -1236.273% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -4563.534% |
| ImmuCell Corporation | 4.39 Million USD | -17484.715% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 828.47% |
| Immix Biopharma, Inc. | -5468.00 USD | 14138249.232% |
| Incyte Corporation | 3.44 Billion USD | 77.531% |
| Innoviva, Inc. | 261.06 Million USD | -196.123% |
| IO Biotech, Inc. | -756 Thousand USD | 102358.466% |
| Jaguar Health, Inc. | 7.72 Million USD | -9908.726% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 116526.807% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -545.557% |
| ContextLogic Inc. | 59 Million USD | -1210.295% |
| MiMedx Group, Inc. | 266.84 Million USD | -189.711% |
| MEI Pharma, Inc. | 49.32 Million USD | -1467.243% |
| NextCure, Inc. | -3.68 Million USD | 21084.636% |
| Onconetix, Inc. | -1.12 Million USD | 68685.7% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 2768.717% |
| Opthea Limited | 21.72 Thousand USD | -3559172.56% |
| Psyence Biomedical Ltd. | -240.00 USD | 322114266.667% |
| Vaxcyte, Inc. | -75 Million USD | 1130.765% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 1348657.374% |
| Precigen, Inc. | 106 Thousand USD | -729215.094% |
| Pharming Group N.V. | 220.1 Million USD | -251.231% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -150011.456% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -76517.839% |
| PureTech Health plc | -1.6 Million USD | 48326.7% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -604.254% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 526.152% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 1805.624% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 3616.05% |
| Acelyrin, Inc. | -115 Thousand USD | 672338.261% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 7691613.282% |
| Summit Therapeutics Inc. | -2.05 Million USD | 37810.927% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 135489.492% |
| Senti Biosciences, Inc. | -2.68 Million USD | 28913.791% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -18983.535% |
| Elevation Oncology, Inc. | -39 Thousand USD | 1982341.026% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 16212.422% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 19710.974% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -2553.967% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -155761.694% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 1405689.091% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -642.633% |
| Seer, Inc. | 7.02 Million USD | -10901.48% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -17558.154% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -3488.183% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 652532.674% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 539575.649% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -126841.544% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -541.694% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -146.459% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 15461580.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -29933.955% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 1523698.739% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -2530.667% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 333321.552% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 157228.862% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 10991.434% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 163008.47% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 7433503.846% |
| Soligenix, Inc. | 97.31 Thousand USD | -794336.395% |
| Century Therapeutics, Inc. | -10.8 Million USD | 7252.132% |
| Kura Oncology, Inc. | -849 Thousand USD | 91157.008% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 1252.054% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 526000.68% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -680.575% |
| Autolus Therapeutics plc | -4.86 Million USD | 15983.994% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -1767.96% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 460263.095% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -716.142% |
| GRI Bio, Inc. | 10.84 Million USD | -7031.021% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -30336.152% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 8999.206% |
| IGM Biosciences, Inc. | -211.66 Million USD | 465.243% |
| INmune Bio, Inc. | 155 Thousand USD | -498657.419% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -1148.122% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 51423.018% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 119318.017% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 2640921.207% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -192206.965% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 38831.162% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 247088.498% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -718.405% |
| Verastem, Inc. | -62 Thousand USD | 1246993.548% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -31648.419% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 296296.935% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -25439.28% |
| Histogen Inc. | 3.76 Million USD | -20411.382% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -134072.54% |
| Surrozen, Inc. | -27.23 Million USD | 2939.053% |
| Organovo Holdings, Inc. | -5.38 Million USD | 14445.407% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 64261.908% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 3114.286% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -3755.346% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 39044241.414% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -12643.49% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 1151690.174% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -399.431% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -530129.081% |
| Apollomics, Inc. | 127 Thousand USD | -608619.685% |
| Amarin Corporation plc | 165.54 Million USD | -366.999% |
| Mesoblast Limited | -9.81 Million USD | 7976.454% |
| Turnstone Biologics Corp. | 16.5 Million USD | -4583.594% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 799.684% |
| Synaptogenix, Inc. | -6347.00 USD | 12180248.101% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 1515931.373% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -379.084% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 56.017% |
| Better Therapeutics, Inc. | -2.72 Million USD | 28428.106% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 789.254% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -128.665% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 6776695.372% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 12449.425% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 69872.022% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -10464.005% |
| Insmed Incorporated | 239.63 Million USD | -222.605% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -21506.316% |
| OmniAb, Inc. | 14.66 Million USD | -5170.839% |
| Alector, Inc. | -95.05 Million USD | 913.308% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -515.402% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 1878.695% |
| Zai Lab Limited | 170.9 Million USD | -352.347% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -844.189% |
| Aura Biosciences, Inc. | -1.29 Million USD | 59796.834% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -594572.308% |
| Immunic, Inc. | -111 Thousand USD | 696563.063% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -4776.208% |
| Veracyte, Inc. | 248.14 Million USD | -211.537% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 111.061% |
| FibroGen, Inc. | 128.9 Million USD | -499.728% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 137069958.156% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 6726.225% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 77.253% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -198633.676% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -117.556% |
| TG Therapeutics, Inc. | 219.1 Million USD | -252.828% |
| Galecto, Inc. | -830 Thousand USD | 93241.446% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 55917.617% |
| Fortrea Holdings Inc. | 424 Million USD | -82.329% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 997.181% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 136444.621% |
| XBiotech Inc. | -1.74 Million USD | 44427.638% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 69872.022% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 1763.562% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 1123.478% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -953.191% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -4500.809% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -98.713% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 1657.141% |
| Vaxxinity, Inc. | -2.23 Million USD | 34704.924% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -136.594% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 6926.959% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -3061.728% |
| NexImmune, Inc. | -1.02 Million USD | 75523.914% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -14316085.185% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 10979.699% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 93.159% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 1156928.827% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 21870.6% |
| Ainos, Inc. | -253.73 Thousand USD | 304780.117% |
| Pluri Inc. | 322 Thousand USD | -239985.093% |
| Prothena Corporation plc | -129.2 Million USD | 698.35% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -1433.149% |
| Celularity Inc. | 6.75 Million USD | -11344.471% |
| Rallybio Corporation | -150 Thousand USD | 515482.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | 2470.884% |
| MeiraGTx Holdings plc | 287 Thousand USD | -269263.763% |
| Omeros Corporation | -69.77 Million USD | 1207.889% |
| Humacyte, Inc. | -76.55 Million USD | 1109.894% |
| Immunocore Holdings plc | 248.39 Million USD | -211.233% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 5196.407% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -1139.258% |
| Blueprint Medicines Corporation | 236.58 Million USD | -226.765% |
| CalciMedica, Inc. | -58 Thousand USD | 1332986.207% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 54312.763% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -2560.726% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 27282.63% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 2604.695% |
| Pulmatrix, Inc. | -8.22 Million USD | 9504.793% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 66174.701% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 193852.882% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 293.853% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -27752.651% |
| Cytokinetics, Incorporated | -322.59 Million USD | 339.644% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -89572.836% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 226807.918% |
| Vor Biopharma Inc. | -3.49 Million USD | 22238.431% |
| Roivant Sciences Ltd. | 109.23 Million USD | -607.716% |
| Evogene Ltd. | 1.39 Million USD | -55159.042% |
| ProKidney Corp. | -3.16 Million USD | 24494.888% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 1860.507% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -11174.231% |
| CorMedix Inc. | -205.56 Thousand USD | 376178.263% |
| BioLineRx Ltd. | 1.1 Million USD | -69672.022% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 1082.667% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 2342748.485% |
| Atai Life Sciences N.V. | -5000.00 USD | 15461580.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 634500.414% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 805385.417% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 55756.875% |
| Sagimet Biosciences Inc. | 2 Million USD | -38553.7% |
| MediciNova, Inc. | 979.7 Thousand USD | -78808.855% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 1016.844% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 817691.878% |
| GeoVax Labs, Inc. | -20.72 Million USD | 3830.914% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -216.14% |
| Biomea Fusion, Inc. | -4.2 Million USD | 18502.142% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 11.379% |
| Mereo BioPharma Group plc | 7.42 Million USD | -10310.369% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 249478.71% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 6442383.333% |
| Absci Corporation | -41.84 Million USD | 1947.294% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 15461580.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 1112.235% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 31513.003% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -261.697% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 82254.516% |
| Allakos Inc. | -6.14 Million USD | 12688.731% |
| Imunon, Inc. | -720 Thousand USD | 107470.643% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 1220.462% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -62.447% |
| BioAtla, Inc. | -103.73 Million USD | 845.268% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 6776695.372% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 434411.236% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 418.375% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 248676.849% |
| XOMA Corporation | 3.86 Million USD | -19922.637% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 1203.052% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -5125.591% |
| aTyr Pharma, Inc. | -2.38 Million USD | 32473.283% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -6104.446% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 2665872.414% |
| Viridian Therapeutics, Inc. | -1 Million USD | 76793.849% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -5946722976.923% |
| Akari Therapeutics, Plc | -4000.00 USD | 19326950.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -21.382% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -396942.751% |
| UroGen Pharma Ltd. | 73.35 Million USD | -953.924% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 2996.059% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -6658590.784% |
| Orgenesis Inc. | -5.72 Million USD | 13603.476% |
| Entera Bio Ltd. | -56 Thousand USD | 1380589.286% |
| GH Research PLC | -315 Thousand USD | 245520.317% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 409133.862% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 147352.19% |
| Xencor, Inc. | -85.26 Million USD | 1006.725% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 349943.649% |
| Replimune Group, Inc. | -2.65 Million USD | 29217.665% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 77311.966% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -334.692% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -396942.751% |
| Portage Biotech Inc. | -54 Thousand USD | 1431718.519% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 817691.878% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 205159.416% |
| OncoCyte Corporation | 413 Thousand USD | -187084.988% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 17198631.702% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 348231631.532% |
| Purple Biotech Ltd. | -196 Thousand USD | 394525.51% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -8520.361% |
| scPharmaceuticals Inc. | 9.78 Million USD | -7803.026% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 7501.409% |
| HilleVax, Inc. | -2.15 Million USD | 35956.865% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 797083.505% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 5152552.679% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 115829.641% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 3361291.304% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 10299294.262% |
| Savara Inc. | -44.26 Million USD | 1846.586% |
| Curis, Inc. | 9.81 Million USD | -7779.666% |
| Daré Bioscience, Inc. | 2.76 Million USD | -27813.626% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 619609.889% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 44812.204% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 339167.544% |
| BeiGene, Ltd. | 2.07 Billion USD | 62.813% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 27750.274% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 293.431% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -1263.735% |
| Erasca, Inc. | -3.73 Million USD | 20814.737% |
| bluebird bio, Inc. | -4.03 Million USD | 19282.978% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 2739748.451% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 59.405% |
| DBV Technologies S.A. | 15.72 Million USD | -4815.272% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 2739748.451% |
| Moderna, Inc. | 2.15 Billion USD | 64.126% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 84588.962% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -9556.183% |
| Molecular Templates, Inc. | 50.39 Million USD | -1434.029% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 144330.224% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -477.835% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 12524.847% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 2064.959% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 795.661% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 21646.098% |
| MacroGenics, Inc. | 50.52 Million USD | -1430.022% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 12777.501% |
| Prime Medicine, Inc. | -147.9 Million USD | 622.683% |
| Aditxt, Inc. | -111.66 Thousand USD | 692446.409% |
| Adagene Inc. | 18.11 Million USD | -4168.417% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -158316.803% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -451.4% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -389.796% |
| SciSparc Ltd. | 2.19 Million USD | -35103.734% |
| Vericel Corporation | 135.57 Million USD | -470.214% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 3086346.956% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 2495335.943% |
| Generation Bio Co. | -73.91 Million USD | 1145.953% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 177004.805% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -1315.394% |
| Invivyd, Inc. | -2.02 Million USD | 38220.02% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 356.971% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 747479.106% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -702.21% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -686.54% |
| ADMA Biologics, Inc. | 88.21 Million USD | -776.322% |
| Clene Inc. | 533 Thousand USD | -144942.026% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -3106.554% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 80880.982% |
| GeoVax Labs, Inc. | -20.72 Million USD | 3830.914% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -38787.022% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 397943.718% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -1452.202% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 11000.649% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 92572.967% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -826.781% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -1057283.193% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -1354.185% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 546.379% |
| Trevena, Inc. | 1.45 Million USD | -53032.234% |
| Surrozen, Inc. | -27.23 Million USD | 2939.053% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 219101.133% |
| Cingulate Inc. | -582.91 Thousand USD | 132721.398% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 2493887.097% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 4024.433% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 10212438.177% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 87849.603% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | -13.569% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 78346.356% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 1372209.616% |
| Kronos Bio, Inc. | 1.37 Million USD | -56246.501% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 1540.528% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 264851.37% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 158414.937% |
| ImmunityBio, Inc. | -17.89 Million USD | 4421.263% |
| Korro Bio, Inc. | -3.63 Million USD | 21396.804% |
| Kineta, Inc. | 5.43 Million USD | -14129.229% |
| BioVie Inc. | -229.37 Thousand USD | 337132.048% |
| Codexis, Inc. | 57.33 Million USD | -1248.369% |
| Celularity Inc. | 6.75 Million USD | -11344.471% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -19164.241% |
| Celcuity Inc. | -142.77 Thousand USD | 541574.519% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -1528016.229% |
| Cibus, Inc. | 1.42 Million USD | -54265.26% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 206804.278% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 3473.07% |
| IN8bio, Inc. | -2.5 Million USD | 31010.596% |
| Kodiak Sciences Inc. | -25.94 Million USD | 3079.435% |
| Annexon, Inc. | -3.26 Million USD | 23763.116% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 37921.624% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 1952.251% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -120692.813% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 0.699% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -346.98% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 40788.105% |
| Arcellx, Inc. | 108.27 Million USD | -613.965% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 2488.316% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -876.054% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 3754.851% |
| Moolec Science SA | -143.3 Thousand USD | 539560.591% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 1926.821% |
| Geron Corporation | -123.5 Million USD | 725.956% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -23419.136% |
| Royalty Pharma plc | 1.79 Billion USD | 56.905% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 1202.973% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 21403034.662% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -333998.56% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 793.875% |
| Humacyte, Inc. | -76.55 Million USD | 1109.894% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 81547.027% |
| 89bio, Inc. | -273 Thousand USD | 283277.289% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 61601.512% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 91264.387% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 628615.447% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -68986.148% |
| Notable Labs, Ltd. | 113 Thousand USD | -684036.283% |
| Liquidia Corporation | 14.6 Million USD | -5195.027% |
| Mustang Bio, Inc. | -2.22 Million USD | 34844.899% |
| Immunovant, Inc. | -231 Thousand USD | 334764.069% |
| Quantum-Si incorporated | 488 Thousand USD | -158316.803% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 1491.447% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 2577013.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -41418.475% |
| Acasti Pharma Inc. | -11 Thousand USD | 7028045.455% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 377915.138% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 119318.017% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 561.504% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -68037.461% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 203006.562% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 39582.84% |
| PepGen Inc. | -1.18 Million USD | 65393.412% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 608819.685% |
| United Therapeutics Corporation | 2.07 Billion USD | 62.653% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 3476.311% |
| Solid Biosciences Inc. | -76.56 Million USD | 1109.723% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 936217.603% |
| Immuneering Corporation | -764.13 Thousand USD | 101269.422% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -1166557.612% |
| Belite Bio, Inc | -399 Thousand USD | 193852.882% |
| XOMA Corporation | 3.86 Million USD | -19922.637% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 3958.425% |
| Bionomics Limited | -434.44 Thousand USD | 178043.556% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 72080.819% |
| uniQure N.V. | 2.21 Million USD | -34801.761% |
| Cassava Sciences, Inc. | -89.42 Million USD | 964.514% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 939.668% |
| Forte Biosciences, Inc. | -9000.00 USD | 8589811.111% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 92683.713% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 177004.805% |
| Altimmune, Inc. | -65.37 Million USD | 1282.559% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -113.539% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 72080.819% |
| Compugen Ltd. | 31.45 Million USD | -2357.714% |
| Peak Bio, Inc. | 367.76 Thousand USD | -210106.407% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -3053.345% |
| Benitec Biopharma Inc. | 108 Thousand USD | -715709.259% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 991220.513% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 64362.178% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 42529.967% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 649742.017% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 64362.178% |
| Instil Bio, Inc. | -4.75 Million USD | 16354.71% |
| argenx SE | 1.1 Billion USD | 30.258% |
| Immunome, Inc. | -8.9 Million USD | 8779.398% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 41003.386% |
| Verona Pharma plc | -679.62 Thousand USD | 113850.25% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 441856.571% |
| Shattuck Labs, Inc. | -2.38 Million USD | 32514.004% |
| CervoMed Inc. | -1.29 Million USD | 59860.194% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 32217.74% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 16283.253% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -31185.876% |
| Moolec Science SA | -143.3 Thousand USD | 539560.591% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 189564.99% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 29037.522% |
| AnaptysBio, Inc. | 14.78 Million USD | -5130.187% |
| Design Therapeutics, Inc. | -537 Thousand USD | 144061.639% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 181147.775% |
| NeurAxis, Inc. | 2.15 Million USD | -35745.16% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -35923.952% |
| Lumos Pharma, Inc. | 2 Million USD | -38418.884% |
| Achilles Therapeutics plc | -4.73 Million USD | 16439.682% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 441856.571% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 731658.079% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -2341.897% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -89572.836% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 75010.271% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 1797.273% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -1797746.512% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 94147.932% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 5875415.397% |
| Palisade Bio, Inc. | 246 Thousand USD | -314157.724% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 2342748.485% |
| Beam Therapeutics Inc. | -59.67 Million USD | 1395.539% |
| Neurogene Inc. | -3.26 Million USD | 23799.387% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -454.831% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 21039.166% |
| Sesen Bio, Inc. | 40 Million USD | -1832.685% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 260394.276% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 19297.092% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 8181.476% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -5390.582% |
| Athira Pharma, Inc. | -969 Thousand USD | 79880.599% |
| Vaccinex, Inc. | -16 Million USD | 4930.505% |
| HCW Biologics Inc. | -574.82 Thousand USD | 134588.817% |
| XOMA Corporation | 3.86 Million USD | -19922.637% |
| Nektar Therapeutics | 53.47 Million USD | -1345.593% |
| Arvinas, Inc. | 71.8 Million USD | -976.705% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 1026.27% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 1331.5% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 240185.093% |
| Rezolute, Inc. | -36 Thousand USD | 2147527.778% |
| Clene Inc. | 533 Thousand USD | -144942.026% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 60208355.452% |
| BeyondSpring Inc. | 1.75 Million USD | -44050.428% |
| Synlogic, Inc. | -1.92 Million USD | 40280.561% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 2089489.189% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 12309.002% |
| Peak Bio, Inc. | 367.76 Thousand USD | -210106.407% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 4176.749% |
| Krystal Biotech, Inc. | 47.6 Million USD | -1523.934% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -447.926% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -15284.557% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 29957.42% |
| MannKind Corporation | 136.19 Million USD | -467.64% |
| Ikena Oncology, Inc. | -50.49 Million USD | 1631.082% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -610.455% |
| Gossamer Bio, Inc. | -4.38 Million USD | 17729.966% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 306875.397% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 15461580.0% |
| Legend Biotech Corporation | 140.92 Million USD | -448.556% |
| Mural Oncology plc | -2.56 Million USD | 30215.855% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 140403.811% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 773174.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -3624.94% |
| REGENXBIO Inc. | 53.02 Million USD | -1357.833% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 14531.226% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 401957.83% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 44734.758% |
| Vaxart, Inc. | -60.76 Million USD | 1372.278% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 294290.578% |
| Cellectis S.A. | 18 Thousand USD | -4294755.556% |
| Longeveron Inc. | 221 Thousand USD | -349707.24% |
| Repare Therapeutics Inc. | -80.07 Million USD | 1065.498% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 29.27% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 59842.968% |
| Revolution Medicines, Inc. | -399.66 Million USD | 293.431% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 2208882.857% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -1577602.041% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 91.018% |
| Denali Therapeutics Inc. | -93.34 Million USD | 928.19% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 3086346.956% |
| Veru Inc. | 7.56 Million USD | -10117.834% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 512069.536% |
| Cingulate Inc. | -582.91 Thousand USD | 132721.398% |
| Passage Bio, Inc. | -3.72 Million USD | 20875.974% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 6418847.924% |
| Exicure, Inc. | -1.42 Million USD | 54427.056% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 201946.997% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -28500.592% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 150892.217% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -1034.771% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 516836.516% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 1405.736% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -197617.136% |
| OmniAb, Inc. | 14.66 Million USD | -5170.839% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -3766.723% |
| Lipocine Inc. | -2.85 Million USD | 27217.62% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 42046.5% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 13650.815% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 51423.018% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -926.441% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 1189444.615% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -817.095% |
| Ocugen, Inc. | -33.53 Million USD | 2405.138% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 24548.893% |
| Q32 Bio Inc. | 578 Thousand USD | -133649.827% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 291826.038% |
| Alumis Inc. Common Stock | -1.28 Million USD | 60308.255% |
| Equillium, Inc. | 35.95 Million USD | -2049.936% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 45388.459% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -154305.118% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 18700487.034% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 298584.17% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -182784.328% |
| Dominari Holdings Inc. | 2.03 Million USD | -37814.37% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 421460.324% |
| vTv Therapeutics Inc. | -13.59 Million USD | 5786.458% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -4363.733% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -67.773% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 66231.223% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 3323.828% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -6509.165% |
| Nkarta, Inc. | -5.86 Million USD | 13272.159% |
| BioCardia, Inc. | -7.24 Million USD | 10764.561% |
| Iterum Therapeutics plc | -1.75 Million USD | 44275.657% |